1. Ipriflavone: Background

   • C. Gennari

   OriginalPaper Pages: S3 - S4

2. Natural and synthetic isoflavones in the prevention and treatment of chronic diseases

   • M. L. Brandi

   OriginalPaper Pages: S5 - S8

3. Ipriflavone inhibits bone resorption in intact and ovariectomized rats

   • M. G. Cecchini
   • H. Fleisch
   • R. C. Mühlbauer

   OriginalPaper Pages: S9 - S11

4. In Vitro and In Vivo effects of ipriflavone on bone formation and bone biomechanics

   • R. Civitelli

   OriginalPaper Pages: S12 - S14

5. Ipriflavone prevents the loss of bone mass in pharmacological menopause induced by GnRH-agonists

   • M. Gambacciani
   • B. Cappagli
   • A. R. Genazzani

   OriginalPaper Pages: S15 - S18

6. Effect of chronic treatment with ipriflavone in postmenopausal women with low bone mass

   • C. Gennari
   • S. Adami
   • L. Vecchiet

   OriginalPaper Pages: S19 - S22

7. Efficacy of ipriflavone in established osteoporosis and long-term safety

   • D. Agnusdei
   • L. Bufalino

   OriginalPaper Pages: S23 - S27

8. Design for an ipriflavone multicenter European fracture study

   • J. Y. Reginster
   • L. Bufalino
   • C. Roux

   OriginalPaper Pages: S28 - S32

9. The future of ipriflavone in the management of osteoporotic syndromes

   • L. V. Avioli

   OriginalPaper Pages: S33 - S35